TREM2 and Alzheimer disease: An arginine-to-histidine substitution at amino acid 47 (R47H) in the triggering receptor expressed on myeloid cells 2 (TREM2) gene, which regulates microglial function in the CNS, increased the risk of developing late-onset AD (Guerreiro et al., 2013).